The U.S. Food and Drug Administration (FDA) approved the Conformable Gore TAG Thoracic Endoprosthesis for endovascular repair of acute and chronic Type B dissections of the descending thoracic aorta. The Conformable Gore TAG Thoracic Endoprosthesis is designed for multiple thoracic etiologies, and is the only device to receive FDA indications for aneurysm, trauma and dissection. Previously, the only approved treatment options were medical management or open surgical repair.

Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the lower extremities –– specifically, the superficial femoral artery (SFA) and proximal popliteal artery (PPA), which carry blood through the upper legs.

Clinicians face the challenge of effectively imaging larger patients. Recognizing this trend, Esaote’s new eHD Technology improves every element of the imaging chain and increases ultrasound’s ability to image with more clarity at greater depth.

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium in late October.

Whole-body magnetic resonance imaging (MRI) may serve as a valuable noninvasive tool for assessing the risk of heart attack and stroke in diabetic patients, according to a new clinical study published online in the journal Radiology. 

Sunshine Heart Inc. has launched a website dedicated to providing information to patients suffering from moderate to severe heart failure to learn about its C-Pulse U.S. pivotal trial, COUNTER HF(TM).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now